Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer

Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer

Purpose: To test the association between the Charlson–Deyo Comorbidity Index (CCI) and the recurrence of non-muscle-invasive bladder cancer (NMIBC). Methods: NMIBC (Ta, T1, TIS) patients who underwent transurethral resection of bladder tumor (TURB) between 2010 and 2018 were identified within a retr...

Full description

Bibliographic Details
Main Authors: Lukas Scheipner, Hanna Zurl, Julia V. Altziebler, Georg P. Pichler, Stephanie Schöpfer-Schwab, Samra Jasarevic, Michael Gaisl, Klara C. Pohl, Karl Pemberger, Stefan Andlar, Georg C. Hutterer, Uros Bele, Conrad Leitsmann, Marianne Leitsmann, Herbert Augustin, Richard Zigeuner, Sascha Ahyai, Johannes Mischinger
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
CCI
NMIBC
recurrence
Charlson comorbidity index
predictor
Online Access:https://www.mdpi.com/2072-6694/15/24/5770

Internet

https://www.mdpi.com/2072-6694/15/24/5770

Similar Items